Novavax (NVAX) Retained Earnings (2010 - 2026)
Novavax (NVAX) recorded quarterly Retained Earnings of -$4.6 billion in Q1 2026, little changed quarter-over-quarter from -$4.6 billion in Q4 2025, and down 1.96% on a YoY basis from -$4.7 billion in Q1 2025.
Novavax (NVAX) Retained Earnings (2010 - 2026) Analysis & Trends
Novavax's Retained Earnings history runs 17 years deep, the most recent figure standing at -$4.6 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 1.96% year-over-year to -$4.6 billion; the TTM figure through Mar 2026 stood at -$4.6 billion (down 1.96% YoY), while the FY2025 annual figure was -$4.6 billion, up 8.79% from the prior year.
- Retained Earnings was -$4.6 billion for Q1 2026 at Novavax, roughly flat from -$4.6 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $3.6 million in Q3 2024 to a low of -$5.0 billion in Q4 2024.
- Historically, Retained Earnings has averaged -$3.0 billion across 5 years, with a median of -$4.5 billion in 2025.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings slumped 348207.47% in 2023, then jumped 130.33% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$4.3 billion in 2022, then decreased by 12.75% to -$4.8 billion in 2023, then fell by 3.89% to -$5.0 billion in 2024, then advanced by 8.79% to -$4.6 billion in 2025, then fell by 0.21% to -$4.6 billion in 2026.
- The last three Retained Earnings figures came in at -$4.6 billion (Q1 2026), -$4.6 billion (Q4 2025), and -$4.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn | -4.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.58 Bn |
| Dec 31, 2025 | -4.57 Bn |
| Sep 30, 2025 | -4.59 Bn |
| Jun 30, 2025 | -4.38 Bn |
| Mar 31, 2025 | -4.49 Bn |
| Dec 31, 2024 | -5.01 Bn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | -4.81 Bn |
| Mar 31, 2024 | -4.97 Bn |
| Dec 31, 2023 | -4.82 Bn |
| Sep 30, 2023 | -11.86 Mn |
| Jun 30, 2023 | -8.18 Mn |
| Mar 31, 2023 | -4.57 Bn |
| Dec 31, 2022 | -4.28 Bn |
| Sep 30, 2022 | -23.79 Mn |
| Jun 30, 2022 | -10.87 Mn |
| Mar 31, 2022 | -1.31 Mn |
| Dec 31, 2021 | -1.35 Mn |
| Sep 30, 2021 | 861,000.00 |
| Jun 30, 2021 | -2.45 Bn |